All Session Tracks

• Track 01 – Advancements in Neuropharmacology
  This track will explore the latest breakthroughs in neuropharmacology, focusing on novel drug formulations and their mechanisms of action. Researchers are invited to present their findings on innovative therapeutic agents targeting neurological disorders. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
• Track 02 – Neuroprotective Agents: Mechanisms and Applications
  This session will delve into the mechanisms by which neuroprotective agents exert their effects on neuronal health. Contributions that discuss both preclinical and clinical applications of these agents in various brain disorders are encouraged. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
• Track 03 – Neurotransmission and Pharmacological Interventions
  This track aims to investigate the intricate processes of neurotransmission and how pharmacological interventions can modulate these pathways. Presentations should focus on the implications of these interventions for treating neurological conditions. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
• Track 04 – Clinical Trials in Neurotherapeutics
  This session will highlight the design, implementation, and outcomes of clinical trials focused on neurotherapeutics. Researchers are invited to share their experiences and insights regarding the challenges and successes in this field. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
• Track 05 – Pharmacotherapy for Neurodegenerative Diseases
  This track will address the current state of pharmacotherapy for neurodegenerative diseases, including Alzheimer's and Parkinson's disease. Discussions will focus on emerging therapies and their potential to alter disease progression. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
• Track 06 – Innovations in Drug Development for Brain Disorders
  This session will showcase innovative approaches in drug development specifically aimed at treating brain disorders. Contributions should emphasize novel methodologies and technologies that enhance therapeutic efficacy. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
• Track 07 – Neurotransmitter Systems and Their Role in Mental Health
  This track will explore the role of various neurotransmitter systems in mental health and disease. Presenters are encouraged to discuss pharmacological strategies that target these systems for therapeutic benefit. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
• Track 08 – Emerging Neurotherapeutics: Challenges and Opportunities
  This session will focus on the emerging landscape of neurotherapeutics, discussing both the challenges faced in development and the opportunities for innovation. Contributions that highlight case studies or novel approaches are particularly welcome. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
• Track 09 – Drug Mechanisms in Neurological Disorders
  This track will investigate the mechanisms of action of drugs used in the treatment of neurological disorders. Researchers are invited to present their findings on how these mechanisms can inform better therapeutic strategies. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
• Track 10 – Translational Research in Neuropharmacology
  This session will emphasize the importance of translational research in bridging laboratory findings with clinical applications in neuropharmacology. Presentations should focus on successful case studies that illustrate this translation. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
• Track 11 – Future Directions in Neuropharmacology Research
  This track will provide a platform for discussing future directions and emerging trends in neuropharmacology research. Participants are encouraged to share visionary ideas that could shape the future of therapeutic interventions in neuroscience. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education

Alignment with the Sustainable Development Goals
Alongside its academic focus, the conference promotes responsible research, ethical practice and knowledge-driven development. Its session tracks collectively contribute to the following United Nations Sustainable Development Goals.

• SDG 3
  Good Health and Well-being
• SDG 4
  Quality Education